Purpose: To report a case of acute retinal necrosis in a patient on anti-tumor necrosis factor α immunosuppressive therapy.
Methods: Case report.
Results: A 47-year-old man with psoriasis presented with blurred vision and floaters in the left eye 4 days after receiving his fourth dose of adalimumab, a tumor necrosis factor α antagonist.